As you move from one life stage to the other, your investment strategies too should be amended in accordance with different life stages. Read on to find out more.

Significant improvement in operating performance on a YOY basis is majorly attributable to better realisations and lower costs in both the operating segments and higher volume in the PVC resin segment.

Despite a gloom & doom scenario in the global markets, the trends on SGX Nifty indicate a positive start for the index in India, as it trades higher by 39 points at 11,813 levels.  In the overnight development, the US stocks went down like ninepins . Travel-related stocks felt the pinch as investors pressed the sell button on the back of concerns that the new restrictions could be imposed.

In India, the festival of Dussehra, which signifies the triumph of good over evil, was celebrated last Sunday. And on Monday precisely, the reverse was seen on the D-Street as the bear, which is a bad character on D-Street, butchered the bulls. As a result, Nifty tumbled 1.36 per cent to settle below the 11,800 mark. Stocks in news: HCL Technologies, Galaxy Surfactants, NTPC and Cosmo Films

Nifty P/E recently registered a high of 33.26 after almost twenty years. So, is it an indication of market crashing? Let’s find out.

India's largest integrated telecommunications company, Bharti Airtel marked its entry into the fast-growing cloud communications market with the launch of Airtel IQ on Monday.

Tata Consultancy Services (TCS) announced today that Volt has partnered with TCS to power Volt 2.0, its next-generation banking as a service (BaaS) platform. Volt is Australia's first neobank

On Monday, the domestic benchmark indices witnessed a sharp decline as Sensex fell by 540 points or 1.33 per cent to close at 40,145.50 levels while Nifty ended at 11,767.75 levels, down by 162.60 points or 1.36 per cent.

Alembic Pharmaceuticals Limited announced that it has received the final approval from US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Timolol Maleate ophthalmic gel-forming solution, 0.25 per cent and 0.5 per cent.

As per the press release on the stock exchanges, the bid for the project stands at the cost of Rs 1,905 crore. The stated project will have a completion period target of 24 months and its operational period will be 15 years from the date of completion.